Divi's Laboratories (NSE:DIVISLAB) Insider Ownership: 0.00 % (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:DIVISLAB Divi's Laboratories Ltd NSE:DIVISLAB
93 GF Score
Price ₹7,248.50
GF Value ₹6,775.95
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Divi's Laboratories Insider Ownership?

Divi's Laboratories NSE:DIVISLAB -0.77% 93 Insider Ownership is 0.00 % as of Jul. 25, 2026. GuruFocus rates NSE:DIVISLAB with a GF Score™ of 93/100 and a GF Value™ of ₹6,775.95 (Fairly Valued). The stock has 7 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Divi's Laboratories's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Divi's Laboratories's Institutional Ownership is 26.13%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Divi's Laboratories's Float Percentage Of Total Shares Outstanding is 0.00%.


Divi's Laboratories Insider Ownership Historical Data

* Premium members only.

The historical data trend for Divi's Laboratories's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories Insider Ownership Chart

Divi's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Divi's Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:DIVISLAB
93GF Score
Divi's Laboratories Ltd NSE:DIVISLAB
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Divi's Laboratories Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
Divi's Laboratories (NSE:DIVISLAB) has a Insider Ownership of 0.00 % as of Jul. 25, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Divi's Laboratories and its competitors.
Is Divi's Laboratories' Insider Ownership too high?
Divi's Laboratories' current Insider Ownership is 0.00 %. Overall, Divi's Laboratories has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Divi's Laboratories' Insider Ownership compare to ZTS and UTHR?
Divi's Laboratories' Insider Ownership of 0.00 % can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Drug Manufacturers company?
A good Insider Ownership depends on the Drug Manufacturers industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Divi's Laboratories and its competitors. Divi's Laboratories's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Divi's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Divi's Laboratories (NSE:DIVISLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,775.95, compared to a current price of ₹7,248.50 — trading 7% above its estimated fair value. The current Insider Ownership is 0.00 %. Divi's Laboratories' overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Divi's Laboratories (NSE:DIVISLAB), the current Insider Ownership is 0.00 % as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Divi's Laboratories stock appears to be overvalued. The current stock price of ₹7,248.50 is trading 7% above its estimated GF Value™ of ₹6,775.95. GuruFocus considers Divi's Laboratories to be Fairly Valued.

Key valuation signals for NSE:DIVISLAB:

  • Insider Ownership: 0.00 %
  • GF Value™: ₹6,775.95 vs. price of ₹7,248.50 (7% above fair value)
  • GF Score™: 93/100 with 7 warning signs

No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Divi's Laboratories Business Description

Other Exchanges 532488:India
Address Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
93GF Score

Get the complete analysis for NSE:DIVISLAB

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7,248.50
Price
₹6,775.95
GF Value